Best Life Sciences Companies in Espoo, Finland
The 32 best Life Sciences companies in Espoo, Finland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Desentum.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Espoo
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Desentum Developing novel types of allergen immunotherapy products (allergy vaccines) | $27M | 32 mo ago | 6 | Janne Janis Co-Founder | Series C | 40 patents Thermosensitive hydrogel drug delivery systems and hypoallergenic peanut protein therapeutics | — |
| 2 | Blueprint Genetics Provider of genetic diagnostics and clinical interpretation for hereditary diseases | $26M | 111 mo ago | 143 | Tero Pekka Alastalo Co-Founder | Acquired | — | — |
| 3 | Mobidiag In vitro diagnostics for infectious diseases | $16M | 82 mo ago | 128 | — | Acquired | 100 patents Molecular diagnostic kits for rapid nucleic acid detection of pathogenic microbes | — |
| 4 | HVR Cardio Provider of mitral valve leakage therapeutics development services | $11M | 45 mo ago | — | Olli Keranen Founder & CSO | Series B | 75 patents Cardiac valve annuloplasty devices and catheter-based valve repair technologies | — |
| 5 | Synoste Limb lengthening device | $11M | 96 mo ago | 15 | Antti Ritvanen Founder & Product Development Director | Acquired | 33 patents Wireless-powered orthopedic bone lengthening and distraction devices with external force generation | — |
| 6 | Beddit Sleep tracker | $8M | 146 mo ago | 6 | — | Acquired | 11 patents Non‑invasive sleep and physiological monitoring, including heart‑rate detection technologies. | — |
| 7 | Pixieray Developer of technology for optical eyeglasses | $4M | 52 mo ago | 33 | Rebecca Melakari Co-Founder | Series A | 134 patents Wearable eye‑tracking optics and ocular drug monitoring with adaptive myopia control | — |
| 8 | Arivin Developer of therapeutics for antimicrobial resistance infections | $4M | 14 mo ago | 2 | — | Seed | — | — |
| 9 | PulseOn Heart rate monitoring wearable and app | $3M | 156 mo ago | 21 | Jaakko Hattula CTO | Seed | 44 patents Wearable cardiac and biometric monitoring hardware with signal quality analysis. | — |
| 10 | Optomeditech Products in the areas of intravenous catheters and blood collection needles | $2M | 142 mo ago | 3 | Ami Rubinstein CEO | Deadpooled | 13 patents Illuminated intravascular catheters and blood‑collection needles for optical guidance | — |
| 11 | Zora Biosciences Provider of diagnostic solutions for cardiovascular diseases and cancer | $2M | 82 mo ago | 7 | — | Funding Raised | 167 patents Lipidomic and ceramide biomarkers for cardiovascular disease diagnosis and risk assessment | — |
| 12 | Maculaser Developer of laser therapy for the treatment of retinal diseases | $1M | 5 mo ago | 5 | Jani Tirronen Co-Founder & CEO | Seed | 22 patents Ophthalmic temperature monitoring and ERG signal acquisition for retinal diagnostics | — |
| 13 | Northern Antibiotics Early-stage Finnish biopharma company developing anti-infectives for severely drug resistant gram negative… | $1M | 158 mo ago | 1 | Martti Vaara Co-Founder | Seed | 89 patents Novel polymyxin analogs reducing toxicity and enhancing pharmacokinetics for Gram‑negative antibiotics | — |
| 14 | Euformatics Bioinformatics tools to interpret next-gen sequencing data | $391K | 52 mo ago | 20 | — | Seed | — | — |
Top 12 Life Sciences companies in Espoo
#1
Seed · Espoo, Uusimaa · founded 2018 · 5 employees$1.5Mraised▾
Developer of laser therapy for the treatment of retinal diseases. It has developed treatment solutions for common retinal diseases including dry age-related macular degeneration. It helps in temperature control of the macula during non-damaging laser treatments. The treatment solutions mechanisms treat the root causes of AMD that reduce oxidative stress, prevent the aggregation of proteins, improve the transport of nutrients, and enhance RPEs cytoprotective mechanisms.
- Feb 2021Seed$1.5M
#2
Seed · Espoo, Uusimaa · founded 2022 · 2 employees$3.5Mraised▾
Developer of therapeutics for antimicrobial resistance infections
- Sep 2025Seed$3.5M
#3
Series C · Espoo, Uusimaa · founded 2011 · 6 employees$26.7Mraised▾
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. By studying the molecular mechanism of the hypersensitivity reaction, the company has made discoveries that allow for improved design of immunotherapeutic products against common types of allergies. The company will be starting clinical trials for the first hypoallergens in 2017.
- Feb 2024Series C$12.9M
- Jan 2022Series B$9.1M
- Jul 2021Grant (prize money)$59.4K
- Dec 2018Grant (prize money)$2.1M
#4
Series B · Espoo, Uusimaa · founded 2002$11.5Mraised▾
Provider of mitral valve leakage therapeutics development services
- Jan 2023Series B$11.5M
#5
Acquired · Espoo, Uusimaa · founded 2000 · 128 employees$16.1Mraised▾
Mobidiag develops and provides rapid and easy-to-use solutions for in vitro diagnostics of infectious diseases. Its Amplidiag product line uses multiplex PCR for gastrointestinal infections. These kits include tests for H. pylori, CarbaR+VRE, C. difficile, and blanket tests for stool parasites, bacterial and viral infections. It also has the Amplidiag Easy and Novodiag instruments for rapid diagnostics, and the Prove-it range of test kits for bone, joint, and herpes diagnostics.
- Jan 2020Conventional Debt$1.7M
- May 2019Conventional Debt$28.1M
- Feb 2019Series B$11.5M
- Nov 2018Conventional Debt$16.9M
#6
Acquired · Espoo, Uusimaa · founded 2012 · 143 employees$26.2Mraised▾
Provider of genetic diagnostics and clinical interpretation for hereditary diseases. The company offers comprehensive clinical-grade NGS with gapless sequencing and medical statements. Its technologies include OS-Seq, a targeted sequencing technology. The company claims to cover more than 2,000 genes with its NGS platform. It also provides targeted NGS panels and Del/Dup analysis, medical Exome, whole Exome, and CNV analysis. It can be used in the diagnostic of diseases like cardiovascular, dermatological, ENT, endocrine, gastric, hematological, hereditary cancer, immunology, metabolic, renal, neural, ophthalmic, and respiratory diseases.
- Jul 2017Series B$16M
- Aug 2014Series A$3.9M
- Series B$6.3M
#7
Acquired · Espoo, Uusimaa · founded 2012 · 15 employees$11Mraised▾
Synoste, a spin-out from Aalto University, is developing a device for the treatment of skeletal deformities. The company is developing a device for limb lengthening using smart materials. The bone of the shorter leg is lengthened gradually over several months. It utilizes electromagnetic induction to transfer the energy needed for the lengthening into the nail. The bone can be stretched approximately 2–7 cm.
- Oct 2018Series A$5.9M
- May 2017Series A—
- Jan 2016Series A—
- May 2015Grant (prize money)$1.1M
#8
Series A · Espoo, Uusimaa · founded 2021 · 33 employees$4.4Mraised▾
Developer of technology for optical eyeglasses. The company offers adaptive eyeglasses integrated with software which allow the user to adjust their lenses to bring into focus that provide a wide and clear field of view for near and intermediate distances.
- 2022Series A—
- Jun 2021Seed$4.4M
#9
Acquired · Espoo, Uusimaa · founded 2007 · 6 employees$8Mraised▾
Beddit is a thin smart sensor that users places under their bed sheet while sleeping. After waking up the user gets a report on their sleep quality, heart rate, breathing rhythm, movement, sleep stages, snoring, and the sleeping environment as well as noise level and light measured. Using the wellness coach, helps the user improve their sleep quality and health. Supports iOS and Android. Raised more than $500k on a goal of $80k with nearly 4000 backers on Indiegogo.
- Sep 2014Series A—
- Seed$500K
#10
Funding Raised · Espoo, Uusimaa · founded 2016 · 7 employees$1.9Mraised▾
Provider of diagnostic solutions for cardiovascular diseases and cancer. Its platform technology uses mass spectrometry for disease-associated metabolomics and for biomarker discovery. Its flagship product CERT (Coronary Event Risk Test) is a metabolomic assay that quantifies risk of coronary events, even when other traditional indicators like LDL are normal. Other diagnostic tests include dSCORE a ceramide-based risk score for the probability of type II diabetes onset.
- Jan 2020Grant (prize money)$1.4M
- Jan 2018Grant (prize money)$480.4K
#11
Seed · Espoo, Uusimaa · founded 2012 · 21 employees$2.7Mraised▾
PulseOn, a spin-off from Nokia, uses a wearable device and an app to track heart rate continuously. It combines optical sensors for heart rate monitoring with analytics to accurately measure heart rate and heart rate variability, training intensity and duration. It also helps monitor specific details recovery time between sessions, fitness level of the user and optimal time for each session. The device is available for €159. The app is available for iOS and Android devices. The product was launched in late 2014.
- Oct 2013Seed$1.4M
- Seed$1.4M
#12
Deadpooled · Espoo, Uusimaa · founded 2011 · 3 employees$2.5Mraised▾
Optomeditech develops products in the areas of intravenous catheters and blood collection needles that enables delivery of medications and fluids, and also allows sampling of blood. They have developed OptiVein IV Catheter with an integrated optical fibre, and an electronic unit. They won the MedTech Nordic Growth reward in 2013.
- Dec 2014Series A$2.5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Finland
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 115 Finland-affiliated papers.
- University of Helsinki28
- University of Turku14
- Helsinki Institute of Physics11
- Helsinki University Hospital11
- Natural Resources Institute Finland11
- Gene3
- Messenger RNA3
- DNA polymerase2
- DNA replication2
- Exon2
- Nutrient4
- Cell3
- Antibody3
- Recombinant DNA3
- Fermentation3
- Production (economics)3
- Gene2
- Functional food2
- Product (mathematics)2
- Sustainability2
Where biotechnology is researched across Finland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.